Articles On ImpediMed (ASX:IPD)

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

It was a mixed bag of results for ASX healthcare shares as we walked through October, as some names came in red hot, whilst others missed the mark completely. After a sharp downturn in late September, where it lost around 7% in just one w...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week With a slew o...

The Impedimed Limited (ASX: IPD) share price has come out of a trading halt today to backtrack mid-afternoon. This comes after the medical technology company provided an update on its recent equity raise. At the time of writing, Impedimed...

The ASX finished in the green by just 0.03%. Today’s gain was spurred by a 1.34% rally in tech shares as well as a rally in Crown (ASX:CWN) shares in the wash-up of the Victorian government’s royal commission. Despite the report finding the...

Market watchers interested in the Impedimed Limited (ASX: IPD) share price have woken to another frosty session as the company’s stock remains frozen for a second day. Impedimed’s shares were halted from trade yesterday while the company u...

The ASX is off to a positive start this week, putting its total gains over the past three weeks up to about 3.6%. The ASX 200 closed 0.34% higher – at 7,441 points. Spurring today’s gains was energy with a 2.64% gain while resources and uti...

ImpediMed is launching a capital raise on Monday morning, on the back of positive clinical trial results last week.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Power says...

As the world emerges from the pandemic, markets are now contending with an energy crisis, a global shipping glut and the prospect of central banks starting to raise interest rates. But so far this week, investors are shrugging it all off as...

Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil...

The Impedimed Limited (ASX: IPD) share price is making good ground today, having climbed 10% from the market open to now trade at 16.5 cents. Impedimed shares are again on the move after coming out of a trading halt that was requested bef...

ImpediMed (IPD) has rounded off its PREVENT trial, successfully meeting its primary end point in the largest recorded trial to assess lymphoedema prevention The findings were based on a 1,200-person trial over six and a half years, spannin...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Wall Street mixed as ‘debt ceiling’ deadline approaches US stock markets finished in mixed territories on Thursday, as a last session selloff turned the Nasdaq from positive to negative at the close. The Dow Jones rose by 0.26%, the S&P...

The Impedimed Limited (ASX: IPD) share price is on the move during mid-afternoon trade. This comes as the medical technology company announced a positive update in regards to its SOZO Heart Failure Program. At the time of writing, Impedime...

Wall Street mixed to end a volatile week The three US stock marker benchmarks finished the week in mixed territories on Friday, after a volatile week of trading. The Dow Jones rose by 0.1%, S&P 500 by 0.15%, but the tech heavy Nasdaq sl...

Wall Street falls again for fourth consecutive day All three major US stock market benchmarks fell on Friday for the fourth consecutive day. Equity investors are concerned about the rising Delta variant cases, and the impending Fed tapering...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow Formwork and Construction Services ((ABC)) - AdBri ((APT)) - Afterpay ((APA)) - APA Group ((AMI)) - Aurelia Metals ((AOF)) - Australian Unity Office Fund (...

Today, Thursday the 26th of August, we are happy to buy Lovisa (ASX:LOV), Zip Co Ltd (ASX:Z1P), Oil Search Ltd (ASX:OSH), Idp Education Ltd (ASX:IEL), Dalrymple Bay (ASX:DBI), Universal Store (ASX:UNI), Acrow Formwork (ASX:ACF), Wagners Hld...

The Impedimed Limited (ASX: IPD) share price is appreciating after the company released its full-year results for FY21. At the time of writing, shares in the healthcare company are trading for 13 cents each – up 4%. For context, the ASX Al...

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

IDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with the Australian Government to potentially assist with the production of a COVID-19 vaccine. There was recent media interest surrounding a mR...

Wall Street rose ahead of world centrals banks meeting this week All three US stock market indexes bounced back on Friday, ahead of this week’s Jackson Hole Economic Policy Symposium, a virtual meeting of world central banks leaders held be...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

ImpediMed (IPD), The A2 Milk Company (A2M), Unibail-Rodamco-Westfield (URW), Harvey Norman Holdings (HVN) & IDP Education (IEL).

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

The market is trading near day’s high at the close, after the Reserve Bank of Australia’s (RBA) maintained status quo in its latest policy announcement and upgraded the country’s GDP growth estimates. The benchmark index ASX 200 was up 35.5...

The Impedimed Limited (ASX: IPD) share price is bouncing this morning after the company announced positive progress in its SOZO technology for heart patients.  The Impedimed share price has been seesawing between the opening price of 12 ce...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

The Impedimed Limited (ASX: IPD) share price was off to a flying start this morning, up 13% at market open. The positive price movement came as the medical technology company announced it received Food and Drug Administration (FDA) clearan...

Wall Street bounces back All major indices in the US have bounced back, after falling the previous day. Both the Dow Jones and S&P 500 rose by 0.93%, while tech heavy NASDAQ also rose by 1.19%. It was a broad-based increase across all s...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The ASX he...

ImpediMed (ASX.IPD) has announced the publication of a peer-reviewed manuscript demonstrating the clinical utility of its SOZO device in monitoring heart failure patients.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The health...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week “Another s...

The Impedimed Ltd (ASX: IPD) share price shot higher this morning, up 5% in morning trade.  This came after the ASX medical technology company reported a significant uptick in the number of tests conducted with one of its leading medical d...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((3PL)) - 3P Learning ((ALD)) - Ampol ((AD8)) - Audinate Group ((BIN)) - Bingo Industries ((BSL)) - BlueScope Steel ((BKG)) - Booktopia Group ((CNU)) - Chorus ((CGC)) - Co...

The Impedimed Limited (ASX: IPD) share price will be closely watched by investors this morning. This comes after the medical technology company announced that it has concluded its long-running Prevent trial. At the closing bell yesterday,...

Summary ImpediMed Limited (ASX:IPD) has secured the Health Information Trust Alliance Certification (HITRUST). HITRUST sets the global standard for safeguarding information. ImpediMed’s goal is to make continuous improvements in safeg...

Summary ImpediMed Limited (ASX:IPD) is an emerging contemporary medical technology company that produces a family of FDA cleared and CE Marked medical devices. The Company uses bioimpedance spectroscopy (BIS) technologies to generate p...

Summary ImpediMed Limited (ASX:IPD) has recently announced the publication of meta-analysis. The meta-analysis demonstrates effectiveness of ImpediMed's BIS L-Dex® technology in reducing rates of long-term breast cancer-related lymphoe...

The Impedimed Limited (ASX: IPD) share price lifted this morning on positive results from a significant cancer screening study. The results show that its bio-impedance spectroscopy (BIS) technology is more effective in screening and detect...

Summary ImpediMed Limited (ASX:IPD) has announced the first order for its SOZO® Digital Health Platform. Phoenix Healthcare Network has initially purchased five SOZO®® units, with implementation likely to commence in early FY21. SO...